BCL2L1 and triple-negative breast carcinoma: We examined the triple negative breast cancer line, MDA-MB-231, which shows a range of responses to Taxol mediated mitotic arrest [39], and generated stable cells co-expressing BadERTam and GFP-Bcl-XL.